Skip to content

Sincalide

Kinevac (sincalide) is a protein pharmaceutical. Sincalide was first approved as Kinevac on 1982-01-01. It is known to target gastrin/cholecystokinin type B receptor and cholecystokinin receptor type A. Kinevac's patent is valid until 2022-08-16 (FDA).
Trade Name Kinevac
Common Name Sincalide
Indication
Drug Class
Sincalide
Get full access now